SHPH - Shuttle Pharmaceuticals Inc
Shuttle Pharmaceuticals Inc Logo

SHPH - Shuttle Pharmaceuticals Inc

https://www.shuttlepharma.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of drugs to sensitize cancers to radiation therapy. The company is headquartered in Rockville, Maryland.

52W High
$56.25
52W Low
$3.00
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.42
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.67
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
1.00
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
5.82%
Institutions (25–75% balanced)
5.67%
Shares Outstanding
1,070,800
Float
987,080
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-46.34
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-5.51%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.0278
Previous
-0.0487
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025